June 2017
Community and Patient Preference Research (CaPPRe) are conducting research on behalf of a pharmaceutical company with people who have high cholesterol.
CaPPRe are specialists in conducting research to determine people’s preferences, in this case what people value, need and expect in the treatment of high cholesterol.
CaPPRe invite you to participate in the research which will involve a 15 – 20 minute online survey.
Your participation will be valuable in improving the understanding of what is important to you in the care of your high cholesterol and helping make better treatments available in Australia for high cholesterol patients. The results will be published so others can also learn from them.
If you are interested in participating in the survey or would like to know more about the research, please click on the link http://bit.do/high_cholesterol.
If you know someone else with a history of high cholesterol who may be interested in this research, maybe a relative or friend, please feel free to forward the link to them.
If you have any questions or require any additional information please contact CaPPRe on (02) 9152 8603 or email [email protected].
CaPPRe respects your privacy. Your details will not be forwarded to any other parties; nor will you be contacted by CaPPRe for anything other than this research project unless you choose to be. All responses are treated with the strictest confidentiality. The report of the research findings will be presented in aggregate form, with no individual person identified. CaPPRe complies with the Privacy Act 1988 (Cth) and the Australian Privacy Principles in relation to the collection and disclosure of information.
Copyright © 2017 FH Australasia Network. All rights reserved.
Our mailing address is:
FHWA
University of Western Australia
Rear 50 Murray Street
PERTH WA 6000
Why did you receive this email?
When you signed up for the National FH Registry you ticked the box for information.
Don’t want to receive emails in the future?
You can unsubscribe by emailing [email protected] with UNSUBSCRIBE in the subject line.